Oxytocin/Methylergometrine Maleate

缩宫素/马来酸甲麦角新碱

Report date: 2022/01/17 12:14:22

Base Information

Drug NameOxytocin/Methylergometrine Maleate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor agonistsDopamine D1 receptor antagonists
TargetsOxytocin receptorDopamine D1 receptor
Therapy Area/IndicationsHemorrhageObstetric Labor Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes OxytocinMethylergometrine Maleate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Gritpharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBroad Medical Nutrition Science (Wuhan) Co LtdNanjing Gritpharma Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageObstetric Labor Complications
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A